vs

Side-by-side financial comparison of GENESIS ENERGY LP (GEL) and Sotera Health Co (SHC). Click either name above to swap in a different company.

GENESIS ENERGY LP is the larger business by last-quarter revenue ($440.8M vs $303.4M, roughly 1.5× Sotera Health Co). Sotera Health Co runs the higher net margin — 11.5% vs 4.5%, a 7.0% gap on every dollar of revenue. On growth, GENESIS ENERGY LP posted the faster year-over-year revenue change (10.5% vs 4.6%). GENESIS ENERGY LP produced more free cash flow last quarter ($87.0M vs $52.4M). Over the past eight quarters, Sotera Health Co's revenue compounded faster (10.6% CAGR vs 0.7%).

Genesis Energy LP is a U.S.-based midstream energy limited partnership that operates critical infrastructure for crude oil, natural gas, refined petroleum products, and specialty industrial materials. Its core assets include pipelines, storage terminals, marine facilities, and rail logistics hubs, serving refineries, industrial clients, and energy distributors across North America.

Sotera Health Co is a global provider of end-to-end medical safety solutions. It offers sterilization services, analytical laboratory testing, and regulatory advisory support for medical device manufacturers, pharmaceutical firms, and food and consumer product companies, helping clients meet industry standards and ensure product safety for end users worldwide.

GEL vs SHC — Head-to-Head

Bigger by revenue
GEL
GEL
1.5× larger
GEL
$440.8M
$303.4M
SHC
Growing faster (revenue YoY)
GEL
GEL
+5.9% gap
GEL
10.5%
4.6%
SHC
Higher net margin
SHC
SHC
7.0% more per $
SHC
11.5%
4.5%
GEL
More free cash flow
GEL
GEL
$34.6M more FCF
GEL
$87.0M
$52.4M
SHC
Faster 2-yr revenue CAGR
SHC
SHC
Annualised
SHC
10.6%
0.7%
GEL

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
GEL
GEL
SHC
SHC
Revenue
$440.8M
$303.4M
Net Profit
$19.9M
$34.8M
Gross Margin
54.7%
Operating Margin
20.4%
23.2%
Net Margin
4.5%
11.5%
Revenue YoY
10.5%
4.6%
Net Profit YoY
140.2%
182.8%
EPS (diluted)
$0.04
$0.12

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GEL
GEL
SHC
SHC
Q4 25
$440.8M
$303.4M
Q3 25
$414.0M
$311.3M
Q2 25
$377.3M
$294.3M
Q1 25
$398.3M
$254.5M
Q4 24
$398.9M
$290.2M
Q3 24
$397.3M
$285.5M
Q2 24
$430.2M
$276.6M
Q1 24
$434.4M
$248.2M
Net Profit
GEL
GEL
SHC
SHC
Q4 25
$19.9M
$34.8M
Q3 25
$9.2M
$48.4M
Q2 25
$-406.0K
$8.0M
Q1 25
$-469.1M
$-13.3M
Q4 24
$-49.4M
$12.3M
Q3 24
$-17.2M
$17.0M
Q2 24
$-8.7M
$8.8M
Q1 24
$11.4M
$6.3M
Gross Margin
GEL
GEL
SHC
SHC
Q4 25
54.7%
Q3 25
57.0%
Q2 25
56.6%
Q1 25
53.2%
Q4 24
56.6%
Q3 24
55.4%
Q2 24
55.2%
Q1 24
51.2%
Operating Margin
GEL
GEL
SHC
SHC
Q4 25
20.4%
23.2%
Q3 25
19.0%
23.4%
Q2 25
17.9%
6.4%
Q1 25
5.5%
-5.8%
Q4 24
3.4%
30.0%
Q3 24
12.2%
28.2%
Q2 24
11.6%
27.8%
Q1 24
13.4%
21.4%
Net Margin
GEL
GEL
SHC
SHC
Q4 25
4.5%
11.5%
Q3 25
2.2%
15.5%
Q2 25
-0.1%
2.7%
Q1 25
-117.8%
-5.2%
Q4 24
-12.4%
4.2%
Q3 24
-4.3%
6.0%
Q2 24
-2.0%
3.2%
Q1 24
2.6%
2.5%
EPS (diluted)
GEL
GEL
SHC
SHC
Q4 25
$0.04
$0.12
Q3 25
$-0.05
$0.17
Q2 25
$-0.12
$0.03
Q1 25
$-4.06
$-0.05
Q4 24
$-0.58
$0.05
Q3 24
$-0.32
$0.06
Q2 24
$-0.25
$0.03
Q1 24
$-0.09
$0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GEL
GEL
SHC
SHC
Cash + ST InvestmentsLiquidity on hand
$6.4M
$344.6M
Total DebtLower is stronger
$3.0B
$2.1B
Stockholders' EquityBook value
$606.0M
Total Assets
$4.9B
$3.3B
Debt / EquityLower = less leverage
3.53×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GEL
GEL
SHC
SHC
Q4 25
$6.4M
$344.6M
Q3 25
$4.9M
$299.2M
Q2 25
$4.5M
$332.4M
Q1 25
$377.4M
$304.4M
Q4 24
$7.4M
$277.2M
Q3 24
$13.0M
$306.7M
Q2 24
$13.7M
$246.1M
Q1 24
$7.0M
$261.1M
Total Debt
GEL
GEL
SHC
SHC
Q4 25
$3.0B
$2.1B
Q3 25
$3.1B
$2.1B
Q2 25
$3.1B
$2.2B
Q1 25
$3.4B
$2.2B
Q4 24
$3.7B
$2.2B
Q3 24
$4.0B
$2.2B
Q2 24
$3.9B
$2.2B
Q1 24
$3.8B
$2.2B
Stockholders' Equity
GEL
GEL
SHC
SHC
Q4 25
$606.0M
Q3 25
$550.5M
Q2 25
$511.3M
Q1 25
$414.1M
Q4 24
$404.9M
Q3 24
$470.2M
Q2 24
$422.8M
Q1 24
$429.4M
Total Assets
GEL
GEL
SHC
SHC
Q4 25
$4.9B
$3.3B
Q3 25
$4.9B
$3.2B
Q2 25
$4.8B
$3.2B
Q1 25
$5.2B
$3.1B
Q4 24
$7.0B
$3.1B
Q3 24
$7.1B
$3.1B
Q2 24
$7.0B
$3.1B
Q1 24
$6.9B
$3.1B
Debt / Equity
GEL
GEL
SHC
SHC
Q4 25
3.53×
Q3 25
3.89×
Q2 25
4.34×
Q1 25
5.36×
Q4 24
5.49×
Q3 24
4.73×
Q2 24
5.26×
Q1 24
5.19×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GEL
GEL
SHC
SHC
Operating Cash FlowLast quarter
$110.8M
$103.1M
Free Cash FlowOCF − Capex
$87.0M
$52.4M
FCF MarginFCF / Revenue
19.7%
17.3%
Capex IntensityCapex / Revenue
5.4%
16.7%
Cash ConversionOCF / Net Profit
5.58×
2.96×
TTM Free Cash FlowTrailing 4 quarters
$65.9M
$149.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GEL
GEL
SHC
SHC
Q4 25
$110.8M
$103.1M
Q3 25
$70.3M
$71.2M
Q2 25
$47.0M
$57.4M
Q1 25
$24.8M
$55.5M
Q4 24
$74.0M
$55.7M
Q3 24
$87.3M
$97.5M
Q2 24
$104.7M
$61.3M
Q1 24
$125.9M
$9.7M
Free Cash Flow
GEL
GEL
SHC
SHC
Q4 25
$87.0M
$52.4M
Q3 25
$43.3M
$35.0M
Q2 25
$-7.6M
$26.2M
Q1 25
$-56.8M
$35.6M
Q4 24
$-47.1M
$-10.2M
Q3 24
$-32.3M
$61.1M
Q2 24
$-67.5M
$19.4M
Q1 24
$-48.3M
$-25.2M
FCF Margin
GEL
GEL
SHC
SHC
Q4 25
19.7%
17.3%
Q3 25
10.5%
11.2%
Q2 25
-2.0%
8.9%
Q1 25
-14.3%
14.0%
Q4 24
-11.8%
-3.5%
Q3 24
-8.1%
21.4%
Q2 24
-15.7%
7.0%
Q1 24
-11.1%
-10.2%
Capex Intensity
GEL
GEL
SHC
SHC
Q4 25
5.4%
16.7%
Q3 25
6.5%
11.6%
Q2 25
14.5%
10.6%
Q1 25
20.5%
7.8%
Q4 24
30.3%
22.7%
Q3 24
30.1%
12.7%
Q2 24
40.0%
15.2%
Q1 24
40.1%
14.1%
Cash Conversion
GEL
GEL
SHC
SHC
Q4 25
5.58×
2.96×
Q3 25
7.63×
1.47×
Q2 25
7.21×
Q1 25
Q4 24
4.52×
Q3 24
5.73×
Q2 24
7.00×
Q1 24
11.09×
1.53×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

GEL
GEL

Onshore Facilities And Transportation Revenue$204.2M46%
Offshore Pipeline Transportation Revenue$154.3M35%
Marine Transportation Revenue$82.2M19%

SHC
SHC

Transferred At Point In Time$198.4M65%
Nelson Labs$55.2M18%
Nordion$49.8M16%

Related Comparisons